Nivolumab‐associated myositis myocarditis and myasthenia and anti‐striated muscle antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nivolumab‐associated myositis myocarditis and myasthenia and anti‐striated muscle antibodies

Published:2020-08 Issue:8 Volume:50 Page:1003-1006
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Fazal Marium¹^ORCID,Prentice David A.¹,Kho Lay K.²,Fysh Edward³

Affiliation:

1. General Medicine DepartmentSt John of God Midland Public Hospital Perth Western Australia Australia

2. Neurology DepartmentSt John of God Midland Public Hospital Perth Western Australia Australia

3. Respiratory DepartmentSt John of God Midland Public Hospital Perth Western Australia Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14946

Reference12 articles.

1. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

2. PD-1 Inhibitor-associated Myopathies: Emerging Immune-mediated Myopathies

3. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

4. Diaphragm thickening fraction to predict weaning—a prospective exploratory study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review;Diagnostics;2024-08-16

2. Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases;Diagnostics;2023-03-25

3. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature;ESMO Open;2023-02

4. Immune Checkpoint Inhibitors Related to Cardiotoxicity;Journal of Cardiovascular Development and Disease;2022-11-03

5. Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody;Internal Medicine;2022-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3